Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy
Phase of Trial: Phase I
Latest Information Update: 05 May 2017
At a glance
- Drugs Cannabidiol (Primary)
- Indications Epilepsy; Generalised epilepsy; Myoclonic epilepsies; Tonic-clonic epilepsy
- Focus Expanded access; Therapeutic Use
- 05 May 2017 Last checked against ClinicalTrials.gov record.
- 05 Aug 2016 Status changed from suspended to recruiting.
- 05 Feb 2016 New trial record